Science Explorer Interactive view Map
Company · Crawley · United Kingdom

Novo Nordisk (United Kingdom)

In research, Novo Nordisk (United Kingdom) stands highest in Medicine (#13,444 of 17,978 worldwide) and Health Sciences (#15,555 of 20,462 worldwide), over all time.

novonordisk.comROR OpenAlex
World rank, all time
#25,172
of 42,892
Rank in United Kingdom
#1,339
of 2,253
Research works
304
▼ 10% vs 2013–17
Citations
6.7k
22.1 per fractional work
Top-10% rate
27.9%
record average 16.5%
Open access
44%
world 28%

What is Novo Nordisk (United Kingdom) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #13,444 of 17,978 17.3%161
Health SciencesDomain #15,555 of 20,462 16.7%174

Each strip is that field’s whole ranked pool, with the notch where Novo Nordisk (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.42× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 1.16× its world share, 1 worksImmunology and Micro…Neuroscience: 1.27× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.53× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.67× its world share, 0 worksChemical EngineeringChemistry: 0.69× its world share, 1 worksChemistryComputer Science: 0.08× its world share, 0 worksComputer ScienceEngineering: 0.15× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.01× its world share, 0 worksMaterials ScienceMathematics: 1.80× its world share, 1 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyDentistry: 0.18× its world share, 0 worksDentistryHealth Professions: 1.38× its world share, 2 worksHealth ProfessionsMedicine: 3.20× its world share, 33 worksMedicineNursing: 0.93× its world share, 0 worksNursingVeterinary: 0.56× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.12× its world share, 0 worksBusiness, Management…Decision Sciences: 1.26× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 1.05× its world share, 1 worksEconomics, Econometr…Psychology: 0.33× its world share, 0 worksPsychologySocial Sciences: 0.06× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.4×. Every wedge is a field page.

Who are the top researchers at Novo Nordisk (United Kingdom)?

Ranked on the composite score, Annemarie Thuri Kristensen and Asger Lundorff Jensen lead among researchers whose main affiliation is Novo Nordisk (United Kingdom).

  1. 1 Annemarie Thuri Kristensen United Kingdom · #1,623,843 worldwide 0 citations · 20 works
  2. 2 Asger Lundorff Jensen United Kingdom · #1,633,700 worldwide 0 citations · 15 works
All ranked researchers at Novo Nordisk (United Kingdom)

Which keywords describe research at Novo Nordisk (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Obesity, Diabetes, Cardiovascular Disease, Heart Failure and Metabolic Syndrome.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control8▲ 93×4 topics
  2. Insulin Therapy7▲ 115×3 topics
  3. Type 2 Diabetes7▲ 60×5 topics
  4. Obesity7▲ 17×15 topics
  5. Diabetes6▲ 23×8 topics
  6. Cardiovascular Disease6▲ 9.5×17 topics
  7. Heart Failure6▲ 24×5 topics
  8. Metabolic Syndrome5▲ 12×16 topics
  9. Clinical Guidelines5▲ 33×4 topics
  10. Cardiovascular Outcomes5▲ 166×1 topic
  11. Glucose Control5▲ 166×1 topic
  12. Insulin Resistance4▲ 17×7 topics
  13. Inflammation4▲ 3.4×23 topics
  14. Lifestyle Intervention4▲ 76×2 topics
  15. Gene Expression3▲ 10×4 topics
  16. Genetic Variation3▲ 28×6 topics
  17. Genome-Wide Association3▲ 78×2 topics
  18. Population Genetics3▲ 44×2 topics
  19. Weight Loss3▲ 37×3 topics
  20. Oxidative Stress3▲ 3.2×15 topics
  21. Cardiovascular Risk3▲ 16×6 topics
  22. Atherosclerosis3▲ 17×7 topics
  23. Haplotype Mapping2▲ 147×1 topic
  24. Mendelian Randomization2▲ 147×1 topic
  25. Health Outcomes2▲ 15×3 topics
  26. Type 1 Diabetes2▲ 50×2 topics
  27. Continuous Glucose Monitoring2▲ 83×1 topic
  28. Glucose Metabolism2▲ 40×2 topics
  29. Hypoglycemia2▲ 83×1 topic
  30. Biomarkers2▲ 5.5×5 topics
  31. Alzheimer's Disease2▲ 13×2 topics
  32. Bariatric Surgery2▲ 107×1 topic
  33. Hepatic Steatosis2▲ 23×2 topics
  34. Metabolic Surgery2▲ 107×1 topic
  35. Clinical Trials2▲ 5.0×4 topics
  36. Cholesterol2▲ 21×2 topics
  37. Global Prevalence2▲ 33×1 topic
  38. Diabetes Mellitus2▲ 14×4 topics
  39. Hepatocellular Carcinoma2▲ 13×3 topics
  40. NAFLD1▲ 22×1 topic

Which research topics does Novo Nordisk (United Kingdom) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Genetic Associations and Epidemiology, Diabetes Management and Research and Bariatric Surgery and Outcomes.

Diabetes Treatment and M…5Diabetes Treatment and Management: 5 fractional worksGenetic Associations and…2Genetic Associations and Epidemiology: 2 fractional worksDiabetes Management and …2Diabetes Management and Research: 2 fractional worksBariatric Surgery and Outcomes: 2 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 2 fractional worksLiver Disease Diagnosis …1Liver Disease Diagnosis and Treatment: 1 fractional worksDementia and Cognitive Impairment Research: 1 fractional worksMaternal and fetal healthcare: 1 fractional worksPancreatic function and diabetes: 1 fractional worksBiomedical and Engineering Education: 1 fractional works
Endocrinology, Diabetes and MetabolismGeneticsSurgeryEpidemiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 5 works
  2. 2 Genetic Associations and Epidemiology Genetics 2 works
  3. 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
  4. 4 Bariatric Surgery and Outcomes Surgery 2 works
  5. 5 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 2 works
  6. 6 Liver Disease Diagnosis and Treatment Epidemiology 1 works
  7. 7 Dementia and Cognitive Impairment Research Psychiatry and Mental health 1 works
  8. 8 Maternal and fetal healthcare Pediatrics, Perinatology and Child Health 1 works
  9. 9 Pancreatic function and diabetes Surgery 1 works
  10. 10 Biomedical and Engineering Education Biomedical Engineering 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.3%not open55.7%

World: 28% of research is openly available.

with international co-authors62.0%domestic only38.0%

World: 19% is written across borders.

How has Novo Nordisk (United Kingdom)'s research output changed?

Output in 2018–2022 was 10% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Crawley

All research institutions in Crawley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.